18F-FDG PET/CT detected recurrent renal cell carcinoma presenting with cardiac metastasis

Cao, Jiahua; Yang, Yuhua

doi:10.1007/s12350-021-02652-4

Cited by 1 publication

(3 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The prognosis depends on many factors and, despite advances, remains poor for MCT patients. Previous studies have shown a median survival ranging from 1 to 18 months 6,21 . The current patient survived for 5 months following pericardiocentesis plus systemic therapy.…”

Section: Discussionmentioning

confidence: 66%

“…Previous studies have shown a median survival ranging from 1 to 18 months. 6,21 The current patient survived for 5 months following pericardiocentesis plus systemic therapy.…”

Section: Discussionmentioning

confidence: 91%

“… 14 Previous study suggested that cardiac metastases can be mistaken for thrombi, endocarditis, or primary tumors in echocardiograms, supplemental imaging with CMR is often needed for further characterization. 18 , 19 Though several studies have confirmed the value of 18F‐FDG PET/CT, 20 , 21 it has not yet achieved the status of a routine examination method to evaluate cardiac metastasis, perhaps due to high FDG uptake by the myocardium. 22 In the current case, the mass was first detected by CMR, whereas no abnormality was found in previous repeated ultrasonography.…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Cardiac metastasis from small cell lung cancer origin: A case report and review of the literature

Tian

Liu

et al. 2022

Cancer Reports

View full text Add to dashboard Cite

Background: Cardiac metastasis from small cell lung cancer (SCLC) origin is rare, whereas the incidence is anticipated to increase with the extended survival rates. Case: We here describe a case report of a 48-year-old male patient diagnosis with SCLC in 2020. In June 2021, he resorted to hospital due to shortness of breath, no obvious changes were found in repeated echocardiography, electrocardiogram and chest computer tomography from June 2021 to September 2021. Due to the persistence of the complaints, cardiac magnetic resonance (CMR) imaging was performed in September 30th, 2021, which showed a mass in the right atrioventricular groove. The patient underwent pericardiocentesis and small cell carcinoma cells were found in the pericardial effusion, confirming the diagnosis of cardiac metastasis. Conclusion:Patients with a history of SCLC who develop new cardiac symptoms of unknown etiology should undergo imaging studies such as CMR. The importance of CMR for patients with SCLC is highlighted. The literature regarding metastatic cardiac tumors is reviewed.

show abstract

Section: Discussionmentioning

confidence: 66%

“…Previous studies have shown a median survival ranging from 1 to 18 months. 6,21 The current patient survived for 5 months following pericardiocentesis plus systemic therapy.…”

Section: Discussionmentioning

confidence: 91%